R-3,3'-bis(3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
|
|
R-3,3'-bis(3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol 속성
- 녹는점
- 195-196 °C
- 끓는 점
- 622.0±55.0 °C(Predicted)
- 밀도
- 1.409±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- 6.77±0.20(Predicted)
안전
R-3,3'-bis(3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol C화학적 특성, 용도, 생산
R-3,3'-bis(3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol 준비 용품 및 원자재
원자재
준비 용품
R-3,3'-bis(3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol 공급 업체
글로벌( 20)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Shanghai Likang New Materials Co., Limited | +86-16631818819 +86-17736933208 |
3684455296@qq.com | China | 9311 | 58 |
Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 |
han_yajun@dctc.daicel.com | China | 7176 | 65 |
Tianjin Derchemist Science & Technology Co., Ltd. | 22-58627059 13920586291 |
zdcomcon@126.com | China | 3166 | 50 |
Bide Pharmatech Ltd. | 400-1647117 15221909166 |
product02@bidepharm.com | China | 41438 | 60 |
Shanghai Chiral bio-compound co., Ltd. | 021-5068 3667/17749785980/1029026415; 17749785980 |
1029026415@qq.com | China | 2884 | 58 |
Zhengzhou Huiju Chemical Co., Ltd. | 0371-55900031 18137872243 |
2853979815@qq.com | China | 10008 | 55 |
LaaJoo | 021-60702684 18516024827 |
huang.jiayi@sinocompound.com | China | 2654 | 58 |
Greenherbs Science and Technology Development Co., Ltd. | 010-61136123 |
pub02@greenherbs.com.cn | China | 4049 | 58 |
Shanghai Anyinuo Biomedical Technology Co., Ltd. | 021-34625901 |
420970979@qq.com | China | 5807 | 58 |
Zhengzhou Acme Chemical Co., Ltd. | 0371-0371-63315541 13323832564 |
3001332135@qq.com | China | 9990 | 58 |
R-3,3'-bis(3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol 관련 검색:
R-3,3'-Bis(4-(1,1-diMethylethyl)phenyl)-1,1'-bi-2-naphthol
R-3,3'-Bis(4-methylphenyl)-1,1'-bi-2-naphthol
R-4-oxide-4-hydroxy-2,6-bis(4-Methoxyphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
R-4-oxide-4-hydroxy-2,6-bis[4-(trifluoroMethyl)phenyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(R)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-bis(4-methoxyphenyl)-[1,1'-binaphthalene]-2,2'-diol
(R)-3,3'-bis(4-Methoxyphenyl)-[1,1'-Binaphthalene]-2,2'-diol
R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
R- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
R-3,3'-Bis(4-(1,1-diMethylethyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
R-3-3'-Bis(3,5-bis(methyl)phenyl)-1,1'-bi-2-naphthol